Higher levels of MCP-1 have been found in CSF and plasma in association with diseases characterized by excessive inflammation including ALS and AD [23,24] and in both of these diseases multiple reports exist that HFE gene variants, particularly the H63D polymorphism, are risk factors for the disease [1,2,25]. The gene discussed is CCL2; the disease is Alzheimer disease.